A review by the US Office of Inspector General found that only about half of the scientists running clinical trials funded by the NIH in 2019 and 2020 appropriately recorded their findings in a federal database, as is legally required.
A new presidential memorandum requires the Department of Health and Human Services to coordinate a government-wide push to generate a research action plan for the condition.
After lobbying efforts from lawmakers and science advisors, the new, DARPA-like biomedical research agency will be a part of the National Institutes of Health, but its director will report directly to the secretary of Health and Human Services.
Geneticist Terry Magnuson steps down as vice-chancellor at the University of North Carolina at Chapel Hill after he copied text from multiple sources he found online into a grant application.
The legislation, passed by the House of Representatives yesterday, will increase research agencies’ budgets by around 5 percent in 2022 and support the creation of a new health agency.
The Scientist spoke with University of Liverpool aging and longevity researcher João Pedro de Magalhães about how human biases can influence scientific priorities and outcomes in genetics.
The revision allows more time on previous extensions due to COVID-19 and other life events such as childbirth that disproportionately impact early-career women in science.
Although many of the hikes are less than what the Biden administration had requested, the draft legislation calls for a boost in spending for agencies like NASA, the National Institutes of Health, and the Department of Energy.
After resigning from the University of New England last year, Geoffrey Bove continues to study the effects of massage on rats in a facility he set up in his house.
A new ruling removes the requirement that grants and proposals using the material receive approval from an ethical review board, reverting to the process in place before 2019.
The members of a new advisory board to the NIH met for the first time and will weigh in on federal funding for grants that rely on donated tissue from abortions.